Promethera Biosciences raised €7.5M in a Series D+ round in Oct 2019. The company is based in Mont-saint-guibert, Belgium. Investors in the round: Sony Innovation Fund. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €7.5M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
